BACKGROUND AND PURPOSE
Few studies have explored the potential clinical advantages of dose escalation and integrated boosts for patients with non-resectable locally advanced rectal cancer. The possibility of escalating dose to non-resectable regions in these patients was the aim of this study.
PATIENTS AND METHODS
Seven patients with locally very advanced… (More)